HEADER IMMUNE SYSTEM 09-OCT-12 4HHA TITLE ANTI-HUMAN CYTOMEGALOVIRUS (HCMV) FAB KE5 WITH EPITOPE PEPTIDE AD-2S1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: FAB KE5; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: FAB FRAGMENT KE5; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: ANTIBODY KE5; COMPND 7 CHAIN: B; COMPND 8 FRAGMENT: AD-2S1 EPTIOPE; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: GLYCOPROTEIN B; COMPND 11 CHAIN: P; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 MOL_ID: 2; SOURCE 5 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 6 ORGANISM_TAXID: 9606; SOURCE 7 MOL_ID: 3; SOURCE 8 SYNTHETIC: YES; SOURCE 9 ORGANISM_SCIENTIFIC: HUMAN HERPESVIRUS 5; SOURCE 10 ORGANISM_COMMON: HHV-5; SOURCE 11 ORGANISM_TAXID: 10359; SOURCE 12 OTHER_DETAILS: SYNTHESIZED PEPTIDE KEYWDS FAB FRAGMENT, ANTIBODY, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR S.BRYSON,L.RISNES,S.DAMGUPTA,C.A.THOMSON,R.PFOH,J.W.SCHRADER,E.F.PAI REVDAT 3 20-SEP-23 4HHA 1 REMARK REVDAT 2 13-DEC-17 4HHA 1 JRNL REVDAT 1 23-OCT-13 4HHA 0 JRNL AUTH S.BRYSON,C.A.THOMSON,L.F.RISNES,S.DASGUPTA,K.SMITH, JRNL AUTH 2 J.W.SCHRADER,E.F.PAI JRNL TITL STRUCTURES OF PREFERRED HUMAN IGV GENES-BASED PROTECTIVE JRNL TITL 2 ANTIBODIES IDENTIFY HOW CONSERVED RESIDUES CONTACT DIVERSE JRNL TITL 3 ANTIGENS AND ASSIGN SOURCE OF SPECIFICITY TO CDR3 LOOP JRNL TITL 4 VARIATION. JRNL REF J. IMMUNOL. V. 196 4723 2016 JRNL REFN ESSN 1550-6606 JRNL PMID 27183571 JRNL DOI 10.4049/JIMMUNOL.1402890 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 48580 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2433 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3431 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 5 REMARK 3 SOLVENT ATOMS : 289 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4HHA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-OCT-12. REMARK 100 THE DEPOSITION ID IS D_1000075465. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-SEP-12 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 4.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.03320 REMARK 200 MONOCHROMATOR : DCM REMARK 200 OPTICS : TOROIDAL FOCUSING MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 48944 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 43.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 3.720 REMARK 200 R MERGE (I) : 0.04780 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.8400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.65 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.69 REMARK 200 R MERGE FOR SHELL (I) : 0.49200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.890 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4HH9 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 34.73 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.88 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.05M NA ACETATE, PH 4.2, 18% REMARK 280 JEFFAMINE 1500, 0.2M AMMONIUM CHLORIDE , VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 32.75500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6260 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19650 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -84.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, P REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 156 REMARK 465 GLY A 157 REMARK 465 ASN A 158 REMARK 465 THR B 160 REMARK 465 CYS B 216 REMARK 465 ASP B 217 REMARK 465 LYS B 218 REMARK 465 THR B 219 REMARK 465 HIS B 220 REMARK 465 THR B 221 REMARK 465 GLY B 222 REMARK 465 LEU B 223 REMARK 465 GLU B 224 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NE2 GLN A 42 O ARG B 55 2445 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 51 -40.96 68.01 REMARK 500 ALA A 84 -164.78 -164.10 REMARK 500 ASN A 138 75.66 40.77 REMARK 500 ALA B 88 173.52 175.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4HH9 RELATED DB: PDB REMARK 900 ANTI-HUMAN CYTOMEGALOVIRUS (HCMV) FAB KE5 REMARK 900 RELATED ID: 4HIE RELATED DB: PDB REMARK 900 ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 REMARK 900 RELATED ID: 4HIH RELATED DB: PDB REMARK 900 ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE REMARK 900 RELATED ID: 4HII RELATED DB: PDB REMARK 900 ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE- REMARK 900 GALACTOSE REMARK 900 RELATED ID: 4HIJ RELATED DB: PDB REMARK 900 ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND L-RHAMNOSE- REMARK 900 (1-2)-ALPHA-D-GALACTOSE-(3-O)-PHOSPHATE-2-GLYCEROL DBREF 4HHA P 1 10 UNP Q9YKI2 Q9YKI2_HCMV 53 62 DBREF 4HHA A 1 214 PDB 4HHA 4HHA 1 214 DBREF 4HHA B 1 224 PDB 4HHA 4HHA 1 224 SEQRES 1 A 215 GLU VAL VAL LEU THR GLN SER PRO ALA THR LEU SER LEU SEQRES 2 A 215 SER PRO GLY GLU ARG ALA THR ILE SER CYS ARG ALA SER SEQRES 3 A 215 GLN SER VAL GLY GLY TYR LEU THR TRP TYR GLN GLN LYS SEQRES 4 A 215 PRO GLY GLN ALA PRO ARG LEU LEU ILE TYR ASP ALA SER SEQRES 5 A 215 ASN ARG ALA THR GLY ILE PRO ALA ARG PHE SER GLY SER SEQRES 6 A 215 GLY SER GLY THR ASP PHE THR LEU THR ILE SER GLY LEU SEQRES 7 A 215 GLU PRO GLU ASP PHE ALA ILE TYR TYR CYS GLN GLN ARG SEQRES 8 A 215 GLY ASN TRP PRO PRO ILE THR PHE GLY GLN GLY THR ARG SEQRES 9 A 215 LEU GLU ILE LYS ARG THR VAL ALA ALA PRO SER VAL PHE SEQRES 10 A 215 ILE PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR SEQRES 11 A 215 ALA SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG SEQRES 12 A 215 GLU ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SEQRES 13 A 215 SER GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER SEQRES 14 A 215 LYS ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SEQRES 15 A 215 SER LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS SEQRES 16 A 215 GLU VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SEQRES 17 A 215 SER PHE ASN ARG GLY GLU CYS SEQRES 1 B 236 GLN VAL GLN LEU VAL GLU SER GLY GLY GLY VAL VAL GLN SEQRES 2 B 236 PRO GLY ARG SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 B 236 PHE THR PHE SER ASN HIS GLY MET HIS TRP VAL ARG GLN SEQRES 4 B 236 ALA PRO GLY LYS ARG LEU GLU TRP VAL ALA VAL ILE SER SEQRES 5 B 236 TYR ASP GLY ARG HIS GLU HIS TYR ALA ASP LEU VAL LYS SEQRES 6 B 236 GLY ARG PHE THR ILE SER ARG ASP ASN SER LYS ASN THR SEQRES 7 B 236 LEU TYR LEU GLN MET ASN SER LEU ARG ALA GLU ASP ARG SEQRES 8 B 236 ALA LEU TYR PHE CYS ALA ARG GLU GLY LEU SER ARG ASP SEQRES 9 B 236 ASN SER GLY PHE THR GLY LEU ILE ASP TYR TRP GLY GLN SEQRES 10 B 236 GLY THR MET VAL THR VAL SER SER ALA SER THR LYS GLY SEQRES 11 B 236 PRO SER VAL PHE PRO LEU ALA PRO SER SER LYS SER THR SEQRES 12 B 236 SER GLY GLY THR ALA ALA LEU GLY CYS LEU VAL LYS ASP SEQRES 13 B 236 TYR PHE PRO GLU PRO VAL THR VAL SER TRP ASN SER GLY SEQRES 14 B 236 ALA LEU THR SER GLY VAL HIS THR PHE PRO ALA VAL LEU SEQRES 15 B 236 GLN SER SER GLY LEU TYR SER LEU SER SER VAL VAL THR SEQRES 16 B 236 VAL PRO SER SER SER LEU GLY THR GLN THR TYR ILE CYS SEQRES 17 B 236 ASN VAL ASN HIS LYS PRO SER ASN THR LYS VAL ASP LYS SEQRES 18 B 236 LYS VAL GLU PRO LYS SER CYS ASP LYS THR HIS THR GLY SEQRES 19 B 236 LEU GLU SEQRES 1 P 10 GLU THR ILE TYR ASN THR THR LEU LYS TYR HET CL A 301 1 HET CL A 302 1 HET CL A 303 1 HET CL A 304 1 HET CL B 301 1 HETNAM CL CHLORIDE ION FORMUL 4 CL 5(CL 1-) FORMUL 9 HOH *289(H2 O) HELIX 1 1 GLU A 79 PHE A 83 5 5 HELIX 2 2 SER A 121 SER A 127 1 7 HELIX 3 3 LYS A 183 GLU A 187 1 5 HELIX 4 4 THR B 28 HIS B 32 5 5 HELIX 5 5 ASP B 61 LYS B 64 5 4 HELIX 6 6 ASN B 73 LYS B 75 5 3 HELIX 7 7 ARG B 83 ARG B 87 5 5 HELIX 8 8 SER B 127 LYS B 129 5 3 HELIX 9 9 SER B 156 ALA B 158 5 3 HELIX 10 10 SER B 187 LEU B 189 5 3 HELIX 11 11 LYS B 201 ASN B 204 5 4 SHEET 1 A 4 LEU A 4 SER A 7 0 SHEET 2 A 4 ALA A 19 ALA A 25 -1 O SER A 22 N SER A 7 SHEET 3 A 4 ASP A 70 ILE A 75 -1 O LEU A 73 N ILE A 21 SHEET 4 A 4 PHE A 62 SER A 67 -1 N SER A 63 O THR A 74 SHEET 1 B 6 THR A 10 LEU A 13 0 SHEET 2 B 6 THR A 102 ILE A 106 1 O ARG A 103 N LEU A 11 SHEET 3 B 6 ILE A 85 GLN A 90 -1 N TYR A 86 O THR A 102 SHEET 4 B 6 LEU A 33 GLN A 38 -1 N THR A 34 O GLN A 89 SHEET 5 B 6 ARG A 45 TYR A 49 -1 O ARG A 45 N GLN A 37 SHEET 6 B 6 ASN A 53 ARG A 54 -1 O ASN A 53 N TYR A 49 SHEET 1 C 4 THR A 10 LEU A 13 0 SHEET 2 C 4 THR A 102 ILE A 106 1 O ARG A 103 N LEU A 11 SHEET 3 C 4 ILE A 85 GLN A 90 -1 N TYR A 86 O THR A 102 SHEET 4 C 4 THR A 97 PHE A 98 -1 O THR A 97 N GLN A 90 SHEET 1 D 4 SER A 114 PHE A 118 0 SHEET 2 D 4 THR A 129 PHE A 139 -1 O LEU A 135 N PHE A 116 SHEET 3 D 4 TYR A 173 SER A 182 -1 O LEU A 179 N VAL A 132 SHEET 4 D 4 GLN A 160 VAL A 163 -1 N GLN A 160 O THR A 178 SHEET 1 E 4 ALA A 153 LEU A 154 0 SHEET 2 E 4 LYS A 145 VAL A 150 -1 N VAL A 150 O ALA A 153 SHEET 3 E 4 VAL A 191 THR A 197 -1 O GLU A 195 N GLN A 147 SHEET 4 E 4 VAL A 205 ASN A 210 -1 O VAL A 205 N VAL A 196 SHEET 1 F 4 GLN B 3 SER B 7 0 SHEET 2 F 4 LEU B 18 SER B 25 -1 O ALA B 23 N VAL B 5 SHEET 3 F 4 THR B 77 MET B 82 -1 O MET B 82 N LEU B 18 SHEET 4 F 4 PHE B 67 ASP B 72 -1 N THR B 68 O GLN B 81 SHEET 1 G 6 GLY B 10 VAL B 12 0 SHEET 2 G 6 THR B 107 VAL B 111 1 O THR B 110 N VAL B 12 SHEET 3 G 6 ALA B 88 GLU B 95 -1 N TYR B 90 O THR B 107 SHEET 4 G 6 MET B 34 GLN B 39 -1 N HIS B 35 O ALA B 93 SHEET 5 G 6 LEU B 45 ILE B 51 -1 O GLU B 46 N ARG B 38 SHEET 6 G 6 GLU B 57 TYR B 59 -1 O HIS B 58 N VAL B 50 SHEET 1 H 4 GLY B 10 VAL B 12 0 SHEET 2 H 4 THR B 107 VAL B 111 1 O THR B 110 N VAL B 12 SHEET 3 H 4 ALA B 88 GLU B 95 -1 N TYR B 90 O THR B 107 SHEET 4 H 4 ILE B 100H TRP B 103 -1 O TYR B 102 N ARG B 94 SHEET 1 I 2 LEU B 97 SER B 98 0 SHEET 2 I 2 ILE P 3 TYR P 4 1 O TYR P 4 N LEU B 97 SHEET 1 J 2 GLY B 100C PHE B 100D 0 SHEET 2 J 2 LEU P 8 LYS P 9 -1 O LEU P 8 N PHE B 100D SHEET 1 K 4 SER B 120 LEU B 124 0 SHEET 2 K 4 THR B 135 TYR B 145 -1 O LEU B 141 N PHE B 122 SHEET 3 K 4 TYR B 176 PRO B 185 -1 O LEU B 178 N VAL B 142 SHEET 4 K 4 VAL B 163 THR B 165 -1 N HIS B 164 O VAL B 181 SHEET 1 L 4 THR B 131 SER B 132 0 SHEET 2 L 4 THR B 135 TYR B 145 -1 O THR B 135 N SER B 132 SHEET 3 L 4 TYR B 176 PRO B 185 -1 O LEU B 178 N VAL B 142 SHEET 4 L 4 VAL B 169 LEU B 170 -1 N VAL B 169 O SER B 177 SHEET 1 M 3 THR B 151 TRP B 154 0 SHEET 2 M 3 ILE B 195 HIS B 200 -1 O ASN B 197 N SER B 153 SHEET 3 M 3 THR B 205 LYS B 210 -1 O VAL B 207 N VAL B 198 SSBOND 1 CYS A 23 CYS A 88 1555 1555 2.02 SSBOND 2 CYS A 134 CYS A 194 1555 1555 2.02 SSBOND 3 CYS B 22 CYS B 92 1555 1555 2.02 SSBOND 4 CYS B 140 CYS B 196 1555 1555 2.03 CISPEP 1 SER A 7 PRO A 8 0 -3.52 CISPEP 2 TRP A 94 PRO A 95 0 -0.18 CISPEP 3 PRO A 95 PRO A 95A 0 -0.96 CISPEP 4 TYR A 140 PRO A 141 0 0.46 CISPEP 5 PHE B 146 PRO B 147 0 -0.69 CISPEP 6 GLU B 148 PRO B 149 0 0.04 SITE 1 AC1 2 PRO A 59 ARG A 61 SITE 1 AC2 3 ASP A 50 ARG A 91 ASN P 5 SITE 1 AC3 5 TRP A 35 ALA A 51 SER A 65 PHE A 71 SITE 2 AC3 5 THR A 72 SITE 1 AC4 6 GLU A 1 VAL A 2 GLN A 90 ASN A 93 SITE 2 AC4 6 PRO A 95A HOH A 417 SITE 1 AC5 2 VAL B 12 GLN B 13 CRYST1 43.250 65.510 67.110 90.00 96.58 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023121 0.000000 0.002667 0.00000 SCALE2 0.000000 0.015265 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015000 0.00000